Post Marketing Information DHCPL 17/11/2022 Risk of major adverse cardiovascular events, malignancy, thrombosis and death associated with use of Janus Kinase (JAK) inhibitors
ORAL Select a brand starting with the letter: J JYSELECA FILM-COATED TABLET 100MG [SIN16980P] JYSELECA FILM-COATED TABLET 200MG [SIN16981P]